Aurobindo Pharma Reports Revenue Of Rs 801 Crore In March Quarter, Stock Edges Lower

INSUBCONTINENT EXCLUSIVE:
Shares of Aurobindo Pharma were last trading 2.27 per cent lower at Rs 975.10 on the BSE.Share Price of Aurobindo Pharma Limited edged lower
by more than two per cent on Tuesday, June 1, a day after the pharmaceutical company announced its January-March quarter results for the
financial year 2020-21
crore for the corresponding quarter of the previous fiscal
The company's revenue from operations for the March quarter stood at Rs 6,0001.50 crore
In the same quarter of the previous fiscal, its revenue from operations stood at Rs 6,158.43 crore.The pharma company stated that the net
profit after the JV share, minority interest is not comparable due to Natrol divestment
For the entire financial year 2020-21, Aurobindo Pharma posted a net profit of Rs 5,333.83 crore, compared to a profit of Rs 2,843.67 crore
low of Rs 959.25, in the session so far
It was last trading 2.40 per cent at Rs 974 on the NSE.Shares of Aurobindo Pharma were last trading 2.27 per cent lower at Rs 975.10 on the
BSE.